Markers of Prostate Cancer Progression
Author Information
Author(s): Devilard Elizabeth, Bladou Franck, Ramuz Olivier, Karsenty Gilles, Dalès Jean-Philippe, Gravis Gwenaëlle, Nguyen Catherine, Bertucci François, Xerri Luc, Birnbaum Daniel
Primary Institution: Centre de Recherche en Cancérologie de Marseille
Hypothesis
The study aims to identify genes associated with the transition from androgen-dependent to androgen-independent prostate cancer.
Conclusion
The study suggests that FGFR1, TACC1, and WT1 may play significant roles in the progression of prostate cancer.
Supporting Evidence
- FGFR1, TACC1, and WT1 gene expression levels were associated with the androgen-independent stage.
- MART1 protein expression was correlated with pT2 tumor stages.
- High expression of FGFR1 and WT1 was found in pT3 tumors compared to pT2 tumors.
- RT-PCR confirmed the correlation between mRNA levels and IHC findings for TACC1 and WT1.
Takeaway
Researchers looked at genes in prostate cancer to see which ones might help doctors understand how the cancer grows and changes.
Methodology
DNA microarrays and immunohistochemistry were used to analyze gene expression in prostate cancer samples.
Potential Biases
Potential bias in sample selection and interpretation of immunohistochemistry results.
Limitations
The study may not fully represent cancer progression in patients due to the use of xenograft models.
Participant Demographics
Patients included 85 men who underwent radical prostatectomy, with a median age of 62.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website